Skip to content
10-K

Annual Report

ABIOMED INC

0000950170-22-010402

← back to feed
Filed
May 20, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · May 12, 2022 45.56M sh
Shares Diluted FY 2022 · Mar 31, 2022 45.88M sh
Shares Diluted FY 2022 · Mar 31, 2021 45.67M sh
Shares Diluted FY 2022 · Mar 31, 2020 45.82M sh
Capex FY 2022 · Mar 31, 2022 $35.76M
Capex FY 2022 · Mar 31, 2021 $53.38M
Capex FY 2022 · Mar 31, 2020 $44.01M
Operating Cash Flow FY 2022 · Mar 31, 2022 $285.39M
Operating Cash Flow FY 2022 · Mar 31, 2021 $274.58M
Operating Cash Flow FY 2022 · Mar 31, 2020 $314.92M
Cash And Equivalents FY 2022 · Mar 31, 2022 $132.82M
Cash And Equivalents FY 2022 · Mar 31, 2021 $232.71M
Stockholders Equity FY 2022 · Mar 31, 2022 $1.5B
Stockholders Equity FY 2022 · Mar 31, 2021 $1.33B
Stockholders Equity FY 2022 · Mar 31, 2020 $1.07B
Stockholders Equity FY 2022 · Mar 31, 2019 $936.89M
Current Liabilities FY 2022 · Mar 31, 2022 $138.46M
Current Liabilities FY 2022 · Mar 31, 2021 $128.97M
Total Liabilities FY 2022 · Mar 31, 2022 $170.07M
Total Liabilities FY 2022 · Mar 31, 2021 $164.68M
Current Assets FY 2022 · Mar 31, 2022 $976.47M
Current Assets FY 2022 · Mar 31, 2021 $787.97M
Total Assets FY 2022 · Mar 31, 2022 $1.67B
Total Assets FY 2022 · Mar 31, 2021 $1.49B
Eps Diluted FY 2022 · Mar 31, 2022 $2.98
Eps Diluted FY 2022 · Mar 31, 2021 $4.94
Eps Diluted FY 2022 · Mar 31, 2020 $4.43
Eps Basic FY 2022 · Mar 31, 2022 $3.00
Eps Basic FY 2022 · Mar 31, 2021 $5.00
Eps Basic FY 2022 · Mar 31, 2020 $4.49
Sga Expense FY 2022 · Mar 31, 2022 $423.49M
Sga Expense FY 2022 · Mar 31, 2021 $334.18M
Sga Expense FY 2022 · Mar 31, 2020 $341.6M
Rd Expense FY 2022 · Mar 31, 2022 $163.4M
Rd Expense FY 2022 · Mar 31, 2021 $121.88M
Rd Expense FY 2022 · Mar 31, 2020 $98.76M
Net Income FY 2022 · Mar 31, 2022 $136.51M
Net Income FY 2022 · Mar 31, 2021 $225.53M
Net Income FY 2022 · Mar 31, 2020 $203.01M
Operating Income FY 2022 · Mar 31, 2022 $140.72M
Operating Income FY 2022 · Mar 31, 2021 $229.56M
Operating Income FY 2022 · Mar 31, 2020 $249.22M
Revenue FY 2022 · Mar 31, 2022 $1.03B
Revenue FY 2022 · Mar 31, 2021 $847.52M
Revenue FY 2022 · Mar 31, 2020 $840.88M
Stock Repurchased FY 2022 · Mar 31, 2021 $11.31M
Stock Repurchased FY 2022 · Mar 31, 2020 $84.88M